Regeneron: Driven by Science
For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.
Regeneron Reports Fourth Quarter and Full Year 2015 Financial and Operating Results02/09/16
TARRYTOWN, N.Y., Feb. 9, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced financial results for the fourth quarter and full year 2015 and provided an update on development programs. Financial Highlights ...